Cresco Labs Inc. (CRLBF)
(Delayed Data from OTC)
$1.60 USD
-0.05 (-3.03%)
Updated Sep 20, 2024 12:23 PM ET
3-Hold of 5 3
B Value C Growth C Momentum B VGM
Cash flow Statements
Fiscal Year End for Cresco Labs Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -179.85 | -215.84 | -296.83 | -36.56 | -65.30 |
Depreciation/Amortization & Depletion | 69.30 | 57.73 | 44.95 | 40.02 | 11.91 |
Net Change from Assets/Liabilities | 15.22 | 13.45 | -29.07 | 2.97 | 21.88 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 153.89 | 163.41 | 295.44 | -17.26 | 6.32 |
Net Cash From Operating Activities | 58.56 | 18.74 | 14.49 | -10.83 | -25.19 |
Property & Equipment | -43.68 | -81.70 | -93.88 | -78.27 | -91.67 |
Acquisition/ Disposition of Subsidiaries | 0.00 | -1.14 | -75.75 | -14.77 | -28.61 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -0.90 | 46.26 | 5.69 | 48.93 | 12.69 |
Net Cash from Investing Activities | -44.59 | -36.58 | -163.93 | -44.11 | -107.60 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 3.22 | 20.10 | 6.20 | 3.18 |
Issuance (Repayment) of Debt | 20.18 | 0.00 | 304.64 | 168.06 | 52.28 |
Increase (Decrease) Short-Term Debt | -3.49 | -2.43 | -3.59 | -7.55 | -2.08 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -43.60 | -87.43 | -86.15 | -24.03 | -4.46 |
Net Cash from Financing Activities | -26.91 | -86.64 | 235.01 | 142.67 | 48.91 |
Effect of Exchange Rate Changes | -0.06 | -2.28 | -0.23 | -1.11 | 0.00 |
Net Change In Cash & Equivalents | -12.99 | -106.76 | 85.33 | 86.62 | -83.88 |
Cash at Beginning of Period | 121.51 | 226.10 | 140.77 | 54.15 | 138.03 |
Cash at End of Period | 108.52 | 119.34 | 226.10 | 140.77 | 54.15 |
Diluted Net EPS | -0.54 | -0.71 | -1.22 | -0.39 | NA |
Fiscal Year End for Cresco Labs Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -53.23 | -2.06 | -179.85 | -184.72 | -71.28 |
Depreciation/Amortization & Depletion | 33.74 | 17.30 | 69.30 | 47.35 | 30.34 |
Net Change from Assets/Liabilities | -4.02 | 10.60 | 15.22 | 43.25 | 21.82 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 77.14 | 10.63 | 153.89 | 155.99 | 40.36 |
Net Cash From Operating Activities | 53.63 | 36.47 | 58.56 | 61.87 | 21.24 |
Property & Equipment | -9.82 | -3.39 | -43.68 | -45.51 | -33.21 |
Acquisition/ Disposition of Subsidiaries | -3.23 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | -2.90 | -2.29 | -0.90 | -1.69 | -1.51 |
Net Cash from Investing Activities | -15.95 | -5.68 | -44.59 | -47.19 | -34.72 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 20.18 | 20.18 | 0.00 |
Increase (Decrease) Short-Term Debt | -1.81 | -0.89 | -3.49 | -2.69 | -1.58 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -25.18 | -10.27 | -43.60 | -40.61 | -31.60 |
Net Cash from Financing Activities | -26.98 | -11.15 | -26.91 | -23.13 | -33.18 |
Effect of Exchange Rate Changes | -0.02 | -0.01 | -0.06 | -0.04 | -0.05 |
Net Change In Cash & Equivalents | 10.68 | 19.63 | -12.99 | -8.49 | -46.70 |
Cash at Beginning of Period | 108.52 | 108.52 | 121.51 | 121.51 | 121.51 |
Cash at End of Period | 119.20 | 128.15 | 108.52 | 113.02 | 74.81 |
Diluted Net EPS | -0.16 | -0.02 | 0.01 | -0.34 | -0.12 |